# Clare Arnott

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/clare-arnott/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,340 |
| Field | Diabetes Treatment and Management |
| h-index | 34 |
| i10-index | 79 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5040550338 |
| ORCID iD | 0000-0001-9370-9913 |
| Works | 226 |

## Researcher papers

- [SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis](https://scholariq.org/papers/sglt2-inhibitors-for-the-prevention-of-kidney-failure-in-patients-with-type-2/)
- [Sex differences in heart failure](https://scholariq.org/papers/sex-differences-in-heart-failure/)
- [Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria](https://scholariq.org/papers/estimated-lifetime-cardiovascular-kidney-and-mortality-benefits-of-combination/)
- [Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data](https://scholariq.org/papers/mortality-in-stemi-patients-without-standard-modifiable-risk-factors-a-sex/)
- [Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome](https://scholariq.org/papers/colchicine-therapy-and-plaque-stabilization-in-patients-with-acute-coronary/)
- [Colchicine in Cardiovascular Disease: In-Depth Review](https://scholariq.org/papers/colchicine-in-cardiovascular-disease-in-depth-review-2/)
- [Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/sodium-glucose-cotransporter-2-inhibition-for-the-prevention-of-cardiovascular/)
- [Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials](https://scholariq.org/papers/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-hyperkalemia-in-people/)
- [Colchicine in Cardiovascular Disease: In-Depth Review.](https://scholariq.org/papers/colchicine-in-cardiovascular-disease-in-depth-review/)
- [Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes](https://scholariq.org/papers/mediators-of-the-effects-of-canagliflozin-on-kidney-protection-in-patients-with/)
- [Prediction of new‐onset heart failure in patients with type 2 diabetes derived from <scp>ALTITUDE</scp> and <scp>CANVAS</scp>](https://scholariq.org/papers/prediction-of-new-onset-heart-failure-in-patients-with-type-2-diabetes-derived/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.